ESSERT GmbH, set up in 2012 by Christopher Essert and headquartered in Bruchsal, Baden-Württemberg, Germany, focuses on modular robotic automation for high-mix, low-volume manufacturing. Operating in India through distributor networks, ESSERT’s core product, the ESSERT MicroFactory, is a scalable platform for pharmaceutical, MedTech, and general industrial applications. With ISO 9001:2015 certification, ESSERT serves clients like Roche and BASF across 10+ countries, focusing on flexible automation for syringes, auto-injectors, and precision medicine. SHS Capital acquired a majority stake in 2023, and ESSERT opened a U.S. subsidiary, ESSERT Robotics Pharma Corp., in New York in 2022. Awards include the 2018 German Innovation Award and the FANUC Innovation Award for the MicroFactory.